Value-Based Health Care: An Introduction (101)

In brief: Value-based health care judges care by the health outcomes achieved per unit of cost over a full cycle of care, not by the volume of services delivered (Busink et al., 2019; Galvin et al., 2019; Sheckter et al., 2019). For example, an NHS study compared two pathways for hip replacement in osteoarthritis: clinical outcomes did not differ significantly, but the intentionally designed multidisciplinary pathway had lower pathway costs and therefore delivered higher value (Gabriel et al., 2019). Whether paying for value improves results at scale is far less certain: Medicare’s hospital programme, for instance, showed no evidence of lower mortality (Figueroa et al., 2016).

Value-based health care: an introduction (101)

This guide introduces value-based health care (VBHC) for students and practitioners of health management, public health, nursing and medicine. It is built on 802 records (678 articles and 124 reviews) from the Web of Science Core Collection, published from 1991 to 2027, and every empirical statement is traced to one of them. It covers definitions, the value agenda, payment models, implementation, effects, critiques, Türkiye, debates and a roadmap for hospital managers. Most included records have authors based in the United States (479) or the Netherlands (96), so transfer to other systems needs care.

Try it yourself: Work through a value equation for a fictional knee replacement pathway, name the VBHC component behind short examples, and run a readiness check for your own organisation.
Open the interactive module: Value Lab

Learning objectives

By the end of this guide you should be able to:

  1. Define value and value-based health care, and explain why definitions differ in their components, perspective and scope.
  2. Describe the main components of the value agenda: outcome measurement with patient-reported outcome measures and standard sets, cost measurement with time-driven activity-based costing, and care organised around medical conditions.
  3. Compare bundled payment, value-based purchasing, shared savings and value-based contracts, and their positive, null and mixed effects.
  4. Evaluate implementation experiences, critiques and equity risks of VBHC using the evidence on outcomes and costs.
  5. Apply a stepwise roadmap and an indicator set to plan or appraise a VBHC initiative in a hospital.

Key concepts

  • Value. Health outcomes achieved per dollar spent (Galvin et al., 2019), with the total cost of a complete care cycle as the denominator (Sheckter et al., 2019).
  • Value-based health care (VBHC). An approach, first described by Michael Porter, that links patient outcomes to costs and shifts the focus from volume to value (Busink et al., 2019).
  • Patient-reported outcomes (PROs). Reports of a patient’s symptoms, function and well-being that come directly from the patient without interpretation by a provider (Moss & Havrilesky, 2018).
  • Standard set. A minimum set of outcomes, with case-mix factors for risk adjustment, defined by the International Consortium for Health Outcomes Measurement (ICHOM) for a condition (Seligman et al., 2019).
  • Time-driven activity-based costing (TDABC). Costing each episode of care from process times and resource costs (French et al., 2016).
  • Integrated practice unit (IPU). A multidisciplinary care team organised around a medical condition (Hernandez et al., 2019).
  • Value-based payment. Contracts that reward better experience, quality and outcomes and lower cost, such as shared savings, capitation and bundled payment (Conrad, 2015).
  • Value-based purchasing (VBP) or pay for performance (P4P). Fee-for-service payment adjusted up or down according to value metrics (Chee et al., 2016).

Contents

  • How this guide was produced; introduction; history and development
  • Definitions of value and VBHC; distinguishing VBHC from neighbouring concepts
  • The value agenda and its components
  • Payment and purchasing models
  • Implementation: enablers, barriers and lessons
  • Effects on outcomes and costs, and critiques of VBHC
  • Themes and bibliometric profile; value-based health care in Türkiye
  • Debates and contradictions; research gaps; implications for practice
  • Summary, discussion questions, further reading, glossary, frequently asked questions and references

How this guide was produced

Database and date. Web of Science Core Collection, Advanced Search, 18 November 2026; no language or year limits; articles and reviews.

Query (verbatim). TI=("value-based health*" OR "value based health*" OR "value-based care" OR "value based care" OR "value-based healthcare" OR "value-based payment*" OR "value-based purchasing" OR "value-based reimbursement" OR "value-based contract*" OR "value-based procurement" OR "value-based medicine" OR "value in health care" OR "value in healthcare" OR "outcomes per dollar") AND DT=("Article" OR "Review")

Criteria. Included: records that substantively address VBHC (concepts, outcome measurement, costing, integrated practice units, value-based payment and purchasing, implementation, effects or critiques). Excluded: “value” in another sense (for example, an economic evaluation only, or values-based practice in ethics), unrelated records, protocols without results and editorial-type content with no substance.

Flow. See Figure 1: 945 identified, 941 screened, 139 excluded with reasons, 802 included (678 articles and 124 reviews), published from 1991 to 2027.

Screening and extraction. AI-assisted screeners worked on titles and abstracts under a common protocol; the lead reviewer resolved 2 unsure records. Evidence was then extracted from the abstracts of a subset of 297 records into a structured template. Statements in this guide rest on that subset; the bibliometric counts cover all 802 records.

Lessons from screening. The largest exclusion group used “value” in another sense. Payment and care redesign are treated in separate sections.

Limitations. A single database was searched. The search used titles only, so studies that discuss VBHC only in the abstract or under other labels (for example, “integrated practice unit” alone) were missed. Evidence was read at abstract level, so numbers are reported as the abstracts state them. Screening and extraction were AI-assisted, with human resolution of unsure records.

Records identifiedWeb of Science Core Collection, 18 Nov 2026n = 9453 duplicates removed1 retracted publication removedRecords screenedtitle and abstract, AI-assisted screenersn = 941Excluded, n = 13971 “value” used in anothersense (E1)53 unrelated to the topic (E3)11 protocols withoutresults (E2)4 editorial-type contentwith no substance (E4)Reason codes from the screening log2 unsure records resolvedby the lead reviewerRecords includedn = 802678 articles and 124 reviewspublication years 1991 to 2027Evidence was then extracted from theabstracts of a subset of 297 recordsinto a structured template (definitions,history, outcome and cost measurement,payment, implementation, effects,critiques, debates, gaps, Türkiye)
Figure 1. Selection of records for this guide, from the Web of Science export and the screening log.

Introduction: why value-based health care matters

More spending does not always buy better health: the United States spends more per capita than any other developed country, and across developed countries spending has risen for two decades without always improving health (Peiffer et al., 2019). Fee-for-service payment, which pays for each item of care, rewards volume (Wise et al., 2022), and rising costs, unknown patient-relevant outcomes and volume-based payment have been called an unsustainable combination (Bernstein et al., 2022).

VBHC asks what health outcomes were achieved and at what cost, and calls for a shift from fee-for-volume to fee-for-value reimbursement (Hamid et al., 2014). Its meaning is contested. A Dutch discourse analysis found four competing readings of VBHC, from a patient empowerment framework to a “dogma of manufacturability” (Steinmann et al., 2020), and an analysis of texts citing the trend-starting article found that more than one-quarter showed no understanding of the aspect they cited, suggesting dilution rather than diffusion of the concept (Fredriksson et al., 2015).

This guide therefore asks what authors mean by value, which components and payment models make up VBHC, what happens when it is implemented, and what the evidence says about outcomes, costs and equity.

History and development

Several sources date the introduction of VBHC to 2006, and a scoping review of 1,242 articles found that the number of publications increased steadily after that year (Douglas et al., 2025; Vijverberg et al., 2022). An early application in 2010 used the relationship between outcomes and costs, following Porter and Teisberg’s 2006 concept of value-based competition, to assess the value created by a multidisciplinary head and neck cancer centre within a comprehensive cancer centre (Feeley et al., 2010). The integrated practice unit was first described in the VBHC context in 2013 (Wiersema et al., 2023).

In the United States, payment reform ran in parallel. Managed care and capitation developed in response to rising fee-for-service Medicare spending, and the Medicare Acute Care Episode Demonstration ushered in bundled payment initiatives (Novikov et al., 2018). The Affordable Care Act established the Hospital Readmission Reduction Program in 2012 and the Hospital Value-Based Purchasing (HVBP) programme (Beauvais et al., 2022); from fiscal year 2013, HVBP introduced quality-based adjustments of up to 1% to Medicare payments for acute care hospitals (A. M. Ryan et al., 2017). In 2015, Congress passed the Medicare Access and CHIP Reauthorization Act (MACRA), which created the Merit-based Incentive Payment System and alternative payment models (Saleh & Shaffer, 2016). Later programmes extended the logic: the Oncology Care Model in 2016 (T. A. Patel et al., 2023), Skilled Nursing Facility Value-Based Purchasing in October 2018 (Qi et al., 2020) and the Transforming Episode Accountability Model in January 2026 (Balu et al., 2026).

Elsewhere, adoption took the form of national programmes and hospital alliances: Wales initiated a national programme for patient-reported outcome and experience measures in 2016 (Withers et al., 2021), and Santeon, an alliance of seven Dutch teaching hospitals, has worked on VBHC since 2012 (Engels et al., 2024). Figure 2 shows milestones stated in the corpus.

Milestones of value-based health care stated in the corpus2006VBHC isintroduced2012Hospital ReadmissionReduction Programestablished (ACA)FY 2013HVBP: paymentadjustments ofup to 1%2013Integrated practiceunit first describedin VBHC context2015US CongresspassesMACRA2016Navy VBHC pilot,Naval HospitalJacksonville2016Wales: nationalPROMs and PREMsprogramme2016CMS launches theOncology CareModelOct 2018Skilled NursingFacility VBPlaunchedJan 2026TransformingEpisode AccountabilityModel beginsNot to scale. Years are as stated in the abstracts; six of the ten concern US Medicare programmes.
Figure 2. Timeline of milestones stated in the corpus. Sources, left to right: Vijverberg et al., 2022; Beauvais et al., 2022; A. M. Ryan et al., 2017; Wiersema et al., 2023; Saleh & Shaffer, 2016; Hernandez et al., 2019; Withers et al., 2021; T. A. Patel et al., 2023; Qi et al., 2020; Balu et al., 2026. ACA: Affordable Care Act; HVBP: Hospital Value-Based Purchasing; MACRA: Medicare Access and CHIP Reauthorization Act; VBP: value-based purchasing.

Definitions of value and value-based health care

Most definitions share a ratio: health outcomes achieved per dollar spent (Galvin et al., 2019), or quality relative to cost, which rises when quality improves, cost falls, or both (MacLean, 2017). The ratio is measured over a full care cycle, so that the denominator is the total cost of that cycle (Bernstein et al., 2022; Sheckter et al., 2019), and care should in theory be organised around medical conditions for specific groups of patients (Steinmann et al., 2022).

VBHC is the management approach built around this ratio, with four dimensions: measure value, benchmark, coordinate care and pay in a way that rewards value added (Busink et al., 2019). It was proposed as a shift in health care management with six reinforcing steps, yet most articles define only its goals or the concept of value (van Staalduinen et al., 2022).

Beyond the ratio, definitions diverge. A scoping review of 46 publications found that definitions vary in components, perspective and scope, and that the precise definition remains ambiguous (Landon et al., 2021). Some authors argue that patients should define value through elicited preferences (Kamal et al., 2018); others give patient, physician and payer each a part of its meaning (Harrill & Melon, 2021). Table 1 lists definitions from different fields.

Source Year Discipline Definition (paraphrased) Emphasised dimension
Feeley et al., 2010 2010 Health care management (cancer centre) The relationship between outcomes and costs, matching outcomes for a patient population with the costs of their care Outcomes matched to costs
van Deen et al., 2015 2015 Gastroenterology (inflammatory bowel disease) Improving outcomes achieved per costs encountered through measurement, benchmarking, improvement and rewards Measurement and improvement cycle
Tsevat & Moriates, 2018 2018 Internal medicine and health economics Maximising outcomes per dollar from the patient perspective, unlike the societal perspective of cost-effectiveness analysis Patient perspective
Sheckter et al., 2019 2019 Breast reconstruction surgery Weighted survival, function, complications, process measures and patient-reported outcomes over the total cost of a complete care cycle Full care cycle
Landon et al., 2021 2021 Health care quality (scoping review) Definitions vary in components, perspective and scope; the precise definition remains ambiguous Variation in definitions
Smith et al., 2023 2023 Health policy The health system’s contribution to societal wellbeing, including responsiveness, financial protection and equity Society and the whole system
Kehyayan et al., 2025 2025 Nursing management (concept analysis) Three attributes: monetary value of services, quality of care and patient-centred care Defining attributes
de Barros e Silva et al., 2025 2025 Cardiology Outcomes that matter to the patient relative to costs, later extended with appropriateness and user experience Extended value equation
Bernz et al., 2026 2026 Health services (payment theory) An organisational and normative paradigm requiring care redesign, unlike pay for performance as a contractual incentive Paradigm, not only a payment tool
Table 1. Selected definitions of value and VBHC, in order of publication year.

Figure 3 brings these elements together.

The value equation and the components built around itOutcomes that matter to patientssurvival, function, complications,process measures and patient-reportedoutcomes (weighted)Costs over the full cycle of caretotal cost of a complete care cycle,direct and indirect costs allocatedto care paths (for example TDABC)Value = outcomes / costsper patient group, per medical conditionComponents that support measuring and raising valueOrganise carearound conditions(IPUs)Measureoutcomes(PROMs, standard sets)Measurecosts(TDABC)Benchmarkand improvewith dataPay forvalue(bundles, VBP, contracts)IntegratedIT platformand dataWhose value? The perspective changes the definitionPatientoutcomes that matter to the personClinician and providercare delivery, team, full cyclePayer and societycoverage, wellbeing, equityConceptual scheme for teaching. Elements follow the cited sources; the arrangement is the author’s synthesis.
Figure 3. Conceptual scheme of value-based health care. Sources: numerator and denominator Sheckter et al., 2019; costing Leusder et al., 2022; medical conditions Steinmann et al., 2022; components Busink et al., 2019; Fuchs et al., 2021; perspectives Landon et al., 2021; Smith et al., 2023; Tsevat & Moriates, 2018.

Distinguishing VBHC from neighbouring concepts

VBHC is often confused with the tools and payment schemes used to pursue it. Pay for performance relies on extrinsic incentives, while VBHC requires redesign of care (Bernz et al., 2026). Table 2 and Figure 4 set out the neighbouring concepts.

Concept What it is Relation to VBHC Source
Value-based health care Linking patient outcomes to costs across four dimensions The umbrella concept Busink et al., 2019
Value Health outcomes achieved per dollar spent The goal VBHC seeks to raise Galvin et al., 2019; Landon et al., 2021
Patient-reported outcome measures (PROMs) Patient reports of symptoms, function and well-being Main source of outcomes that matter to patients Moss & Havrilesky, 2018
ICHOM standard set Minimum outcome set with case-mix factors Standardises the numerator across providers Seligman et al., 2019
Time-driven activity-based costing (TDABC) Episode costing from process times Measures the denominator French et al., 2016; Leusder et al., 2022
Integrated practice unit (IPU) Multidisciplinary team for one condition Organises delivery Hernandez et al., 2019; Wiersema et al., 2023
Bundled payment Payment for an episode or a chronic condition Pays for the whole episode Conrad, 2015; Wise et al., 2022
Value-based purchasing (VBP) A payer adjusts fee-for-service payments up or down by value metrics; the term also describes device purchasing on price and performance Payer lever, often tied to process measures rather than outcomes that matter to patients Chee et al., 2016; Robinson, 2008; Strazzabosco et al., 2017
Pay for performance (P4P) Bonuses or penalties tied to performance metrics An incentive, not a care redesign Bernz et al., 2026; Chee et al., 2016
Table 2. VBHC and neighbouring concepts.
Value-based health care and its neighbours: which features are central?PatientoutcomesCostsCareorganisationPaymentincentiveFull cycleof careCondition-specificValue-based health careValuePatient-reported outcome measuresICHOM standard setTime-driven activity-based costingIntegrated practice unitBundled paymentValue-based purchasingPay for performancecentralpartly or sometimesnot centralAuthor’s synthesis for teaching, not an empirical rating.
Figure 4. Matrix comparing value-based health care (shaded row) with eight neighbouring concepts on six features. The ratings are the author’s synthesis, not a finding of the corpus; see Table 2 for cited evidence on each concept.

The value agenda and its components

The components of VBHC are often organised as a strategic agenda. A scoping review used Porter and Lee’s agenda to categorise 1,242 articles: most applications measured outcomes and costs (agenda item 2), and the other items were far less often described or implemented (Vijverberg et al., 2022). Table 3 summarises the building blocks.

Outcome measurement. Clinicians gather more data than ever, but what is measured often has little relationship to the results that matter most to patients (Seligman et al., 2019). ICHOM working groups define minimum standard sets of outcomes, with case-mix factors for risk adjustment (Seligman et al., 2019). Patients can help choose outcomes: in a psoriasis clinic, 120 patients ranked symptom control and treatment efficacy as most important and cost of care among the least important (Hilhorst et al., 2023). Fair comparison needs case-mix adjustment, and in four Dutch stroke centres the predictors for the EQ-5D differed considerably from those for clinical outcomes (Oemrawsingh et al., 2019).

Collection at scale is possible: a national platform in Wales, integrated with patient administration systems, had collected over 110,000 PROMs (Withers et al., 2021). Use lags behind. In three Dutch forerunner projects, individual PROM scores were largely used in consultations, but aggregated PROM information on treatment options was scarcely used (Damman et al., 2020). Of 47 value agenda applications, only 16 used patient-reported outcome surveys and only 3 reported outcomes at all six levels of an outcome hierarchy (Zanotto et al., 2021). A scoping review of 43 studies found little robust evidence that PROMs in VBHC programmes have an effect (Bianchim et al., 2023).

Cost measurement. Of 215 studies that measured costs in a VBHC setting, about half (110, 51.2%) measured hospital costs and the rest relied on reimbursement amounts; TDABC was viewed as the best method, although its usefulness depends on how it is implemented (Leusder et al., 2022). In a TDABC study of anaesthesia for 11 outpatient oncologic procedures, personnel made up 79% of cost, and modelling different staffing ratios showed potential savings of 13% to 28% (French et al., 2016). At a university hospital in Verona, TDABC showed that the da Vinci system cost more per robot-assisted radical prostatectomy than the Hugo system overall but less once surgical kit costs were excluded (Landi et al., 2025). Pairing PROMs with TDABC costs gives a patient-level value analysis in six steps, from defining the care pathway to identifying value drivers (Jayakumar et al., 2026).

Organising care around conditions. The integrated practice unit is one of four condition-based organisational models, which differ in staff, colocation, independence and leadership (Wiersema et al., 2023). Full reorganisation is rare: Dutch hospitals often use liaison devices such as project teams and committees, while forming units around medical conditions is much rarer (Steinmann et al., 2022).

Benchmarking. In the VOICE community of six European centres, benchmarking of 690 patients with breast cancer found significant differences across sites in most health outcomes, half of the care-process indicators and all economic indicators (Garcia-Lorenzo et al., 2024).

Component What it is Example as stated Citation
Definition of value Outcomes per dollar across a full care cycle A six-component strategic agenda for hand surgery Bernstein et al., 2022
PROMs Routine patient-reported outcomes Wales: over 30 national PROMs pathways Withers et al., 2021
Standard sets (ICHOM) Minimum outcome sets with case-mix factors 24 sets, including heart failure and stroke Seligman et al., 2019
Tiered outcome set Outcomes ordered in tiers Pituitary surgery, 103 adults: complete resection in 70% Lobatto et al., 2019
Costing (TDABC) Episode costs from process times Anaesthesia: personnel 79% of cost French et al., 2016
Outcomes and costs together Outcomes and costs side by side Prostate cancer: PROMs and 12-month TDABC costs on radar charts Thaker et al., 2016
Integrated practice unit Team organised around a condition Sarcoma: VBHC delivery principles partially integrated in seven Swiss referral hospitals; IPUs proposed Fuchs et al., 2021
Benchmarking Risk-adjusted comparison Six European centres, 50 indicators Garcia-Lorenzo et al., 2024
Table 3. Components of the value agenda with examples as stated in the sources.

Payment and purchasing models

A scoping review of value-based payment schemes active between 2010 and 2024 identified 61 schemes across 15 countries: 38 pay for performance, 18 bundled payment and 5 shared savings (Kumru & Or, 2027). In the United States, many models are layered on top of the fee-for-service architecture of the Medicare Physician Fee Schedule (Berenson & Ginsburg, 2019). The findings below are grouped by direction of effect.

Positive findings. In Medicare Advantage, full-risk capitation with a revenue gainshare was associated with fewer emergency department visits and admissions, savings of $2,071,293 per 1,000 enrollees and a 32.8% lower hazard of death compared with a fee-for-service provider group (Mandal et al., 2017). In community health clinics in Washington State, a natural experiment linked value-based payment to clinically significant improvement in depression (hazard ratio 1.45) (Bao et al., 2017). A review of orthopaedic models reports that early bundled programmes achieved savings mainly through reduced post-acute care (Balu et al., 2026).

Null findings. For Medicare’s Hospital Value-Based Purchasing (HVBP) programme, an observational study of 4,267 hospitals and 2,430,618 patients found a small, non-significant difference in 30-day mortality trends (P = 0.35), with no benefit in any subgroup (Figueroa et al., 2016). In a systematic review of 33 studies, the 7 impact studies reported no impact on processes or patient outcomes, and none evaluated costs (Hong et al., 2020). The Nursing Home Value-Based Purchasing demonstration had little impact on quality or Medicare spending (Grabowski et al., 2017), and the physician Value-Based Payment Modifier was not associated with significant differences in quality or spending (Roberts et al., 2018). Episode-based payment models for heart failure hospitalisation yielded limited success (Joynt Maddox et al., 2020).

Mixed findings. Over the first four years of HVBP, improvements in clinical process and patient experience were not significantly greater than in control hospitals, but mortality fell significantly for pneumonia (-0.431 percentage points), though not for acute myocardial infarction or heart failure (A. M. Ryan et al., 2017). Under the Comprehensive Care for Joint Replacement bundle, a single centre (1,248 knee arthroplasty patients) found no biased patient selection and no significant change in direct hospital costs, although length of stay and discharge to inpatient facilities appeared to improve (S. P. Ryan et al., 2019). In Swedish spine surgery, a bundle gave a fuller picture of needs but added administration and led providers to reduce post-discharge care, while the performance payment, though appreciated, was neglected because of its limited financial impact and unclear calculation (Eriksson et al., 2023). Home Health VBP slightly raised quality but not patient experience star ratings (Teshale et al., 2021). A value-based programme in 73 community pharmacies was associated with a 4.5% lower total cost of care, while lower admissions and emergency visits were not statistically significant (Doucette et al., 2021). In networks of care, most shared savings and pay-for-performance studies showed positive clinical and cost effects but no change in patient satisfaction or access, and providers’ opinions were frequently negative (Leao et al., 2023). For Medicare overall, some episode-based and population-based models showed modest savings, but efficacy remains suboptimal (Figueroa et al., 2025). Larger prior-year HVBP penalties were associated with some care process improvements, while bonus hospitals were less apt to improve (Lee et al., 2020).

Unintended effects. After a spending metric was added to HVBP in fiscal year 2015, low-quality hospitals began to receive bonuses (0% to 17%) (Das et al., 2016). A cross-sectional study of 3,276 hospitals in 2019 found HVBP participation positively associated with readmission rates (+0.19% to +0.37%), although the authors note that this does not prove the programme is not working (Beauvais et al., 2022). The Skilled Nursing Facility programme penalised 72% of 14,558 facilities in its first year (Qi et al., 2020), and physician practices serving high-risk patients received fewer bonuses and more penalties (Chen et al., 2017).

Contracts and procurement. Of 23 publicly reported US contracts for cell and gene therapies, none disclosed assessment methods, adjudication or performance results (P. M. Patel et al., 2026). Legal frameworks allowing value-based award criteria for medical devices existed in all 15 countries examined, but operational maturity varied substantially (Seechoonparsad et al., 2026).

Syntheses. In 80 studies of 44 incentive schemes from 10 countries, the proportion of positive and significant outcomes was close to .5, and stronger designs found fewer positive effects (Scott et al., 2018). In commercial insurance, more studies found positive results for quality (81%) than for spending (56%), and less rigorous studies were more likely to be positive (Milad et al., 2022). In hospitals, only 3 of 12 studies found a positive relationship between pay for performance and efficiency (Mokhtary et al., 2024).

Implementation: enablers, barriers and lessons

Implementation is usually partial. Of 50 initiatives worldwide (47 from high-income countries), adoption remained mostly at departmental or institutional level, with few systemwide or national examples, and none achieved full implementation of all aspects (Douglas et al., 2025). Most hospitals implemented only one or two components, mainly outcome and cost measurement or IPUs (van Staalduinen et al., 2022).

Enablers. Leadership with a clear mandate recurs. At a Swedish university hospital, top management’s explicit decision helped, but team leaders’ lack of a mandate obstructed implementation (Nilsson et al., 2018). A scoping review of 145 studies lists strong leadership, multidisciplinary collaboration and digital tools as facilitators (Khalil et al., 2025), and organisations in the top quartile of a culture index earned an additional 1% on value-based purchasing (Owens et al., 2017).

Barriers. The same review names insufficient funding, the persistence of fee for service and professional resistance (Khalil et al., 2025). US payment reform projects met incompatible information systems, billing transaction costs and insufficient scale to bear risk (Conrad et al., 2014). Patients are rarely partners: in 21 studies, engagement relied mostly on questionnaires or interviews, and no example had patients co-leading improvement committees (van der Voorden et al., 2023).

Lessons. VBHC can trigger improvements, but its structure alone does not sustain them without engaging all staff (Nilsson et al., 2017); implementation works better as a dynamic process than as planning and execution (Colldén & Hellström, 2018), and varying frames of reference lead to fragmented implementation (Engels et al., 2024). Table 4 summarises experiences with settings as stated in the sources.

Setting What was implemented Result or lesson Citation
Naval Hospital Jacksonville (Navy pilot, from 2016) Pilot with IPUs for four conditions Outcomes improved for three of four conditions Hernandez et al., 2019
Four pilot teams, Swedish university hospital VBHC as a management strategy Improvements triggered; structure alone was not enough Nilsson et al., 2017
Psychiatric department, large Swedish hospital (from 2015) Two-year VBHC implementation Content modified and plans not followed, yet perceived as successful Colldén & Hellström, 2018
Community wound care, Ontario, Canada Integrated Client Care Project Underwhelming outcomes; autonomy of organisations, a powerless team and opaque goals undermined it Dainty et al., 2018
Amsterdam UMC, the Netherlands Step-by-step approach for 14 patient groups Organisational readiness and clinical leadership were key Heijsters et al., 2022
Dutch hospitals Value-based redesign of structures Liaison devices common; condition-based units rare Steinmann et al., 2022
Santeon, seven Dutch teaching hospitals (since 2012) System-wide improvement initiatives in breast cancer care Outpatient breast-conserving surgeries rose from 391 in 2014 and 2015 to 458 in 2016 Engels et al., 2024
Seven major referral hospitals, Switzerland VBHC delivery principles for sarcoma, partially integrated; IPUs through a supraregional network proposed The authors argue that an integrated IT platform is key Fuchs et al., 2021
Spine surgery providers, Sweden Bundled payment combined with performance-based payment More administration, less post-discharge care Eriksson et al., 2023
Six US states (State Innovation Models, Round 1) Multipayer value-based payment models State levers aligned payers; voluntary engagement did not Kissam et al., 2019
Table 4. Implementation experiences, with settings as stated in the sources.

Effects on outcomes and costs, and critiques of VBHC

In the records read for this guide, evidence on VBHC delivery programmes, as distinct from payment programmes, comes mostly from single sites and non-randomised comparisons, and few studies examined effects (van Staalduinen et al., 2022). Positive findings: in a digital transmural pathway with weekly PROMs for 221 patients with lung cancer, patients had fewer emergency department visits than with routine care (3.5% vs 4.8%) and, in stage IV, longer overall survival (447 vs 286 days) (Demedts et al., 2021). In a quality improvement project in a large primary care group in Southern California, a cardiometabolic care team for patients with diabetes improved glycaemic and lipid control more than usual care, with a 12.6% reduction in total health care costs against a 51.7% increase under usual care (Fortmann et al., 2020).

Null and mixed findings: in a pilot VBHC programme for inflammatory bowel disease (60 patients and 177 matched controls in claims data), only the reduction in upper endoscopies was significant; fewer surgeries, hospitalisations and emergency visits and 16% lower costs were not statistically significant (van Deen et al., 2017). In NHS hip replacement pathways, clinical outcomes did not differ significantly, and the designed pathway had lower costs with a small but inconsistent positive financial margin (Gabriel et al., 2019). A narrative review of 49 randomised and cohort studies found that VBHC interventions appeared to improve safety culture and process metrics, but effect sizes varied and certainty was moderate (Wang et al., 2026).

Critiques. Five lines of critique recur. First, the concept is diluted: a Dutch Delphi study asked whether VBHC’s international uptake reflects actual implementation or an inspiring idea (Steinmann et al., 2021). Second, measures may not measure value: HVBP total performance scores did not correlate well with hospital-acquired conditions (Spaulding et al., 2014), and cases flagged by the patient safety indicator composite (PSI 90) used in HVBP had a positive predictive value of 63.3% at one institution (Nguyen et al., 2018). Third, payment often rewards process compliance rather than outcomes that matter to patients (Strazzabosco et al., 2017). Fourth, equity: safety-net hospitals had lower patient experience scores and 60% lower odds of meeting value-based purchasing performance benchmarks for hospital payments (Chatterjee et al., 2012) and were more often penalised under HVBP (62.9% vs 51.0%) and the readmissions programme (80.8% vs 69.0%), although most penalties were small (Gilman et al., 2015), and adjusting for cognitive, functional and social factors eliminated safety-net providers’ performance gap on a hospitalisation measure (Johnston et al., 2019). Fifth, normative concerns: incentive-based reforms are not neutral technical instruments and raise risks for professional autonomy, workforce well-being and equity (Bernz et al., 2026), and the current model has been criticised for focusing on population health while overlooking individual patients’ preferences (Kamal et al., 2018).

Themes and bibliometric profile

Growth. The literature is recent (Figure 5): 13 included records appeared from 1991 to 2009, compared with 53 in 2010 to 2015, 261 in 2016 to 2020 and 388 in 2021 to 2025; 85 appeared in 2026 up to the search date, and 2 already carry the year 2027.

Included records per publication year, 1991 to 2027 (n = 802)1991 to 200913 records2010 to 201553 records2016 to 2020261 records2021 to 2025388 records2026 to 202787 records020406080100111995200011200522552010312951920152853446670202062836290912025852Alternating shaded bands mark five periods; counts per period are shown at the top.Orange bars: 2026 (part of the year; searched 18 November 2026) and 2027 (2 records). Empty years have no records.
Figure 5. Included records per publication year, with counts for five periods. The 2026 count covers part of the year only.

Themes. Keyword matches in titles, abstracts and author keywords show where attention goes (Figure 6). Implementation matched 336 records and value-based payment or bundled payment 288, followed by critique (175), value-based purchasing including HVBP (138), PROMs (78), value-based or outcome-based contracts (69), oncology (64), Porter or the value equation (55) and orthopaedics (42). The delivery-side tools are much less visible: TDABC or costing matched 25 records, integrated practice units 24 and ICHOM or standard sets 13. A record can match several groups, so the counts overlap and do not add up to 802. The imbalance echoes a scoping review in which agenda items other than outcome and cost measurement were far less often described or implemented (Vijverberg et al., 2022).

Records matching each theme keyword group (a record can match several)050100150200250300350Implementation336Value-based payment or bundled payment288Critique175Value-based purchasing (incl. HVBP)138PROMs78Value-based or outcome-based contracts69Oncology64Porter or value equation55Orthopaedics42TDABC or costing25Integrated practice units24ICHOM or standard sets13Keyword matches in title, abstract and author keywords of the 802 included records. Counts overlap.
Figure 6. Included records matching each theme keyword group. Counts overlap and do not add up to 802.

Countries, journals and fields. By affiliation address, the United States leads with 479 records, followed by the Netherlands (96), the United Kingdom (58), Australia (40), Italy (38), Sweden (23), Spain (22) and Germany (22); a record can count for several countries. The most frequent journals were BMC Health Services Research (28 records), Health Affairs (18), Frontiers in Public Health (18), NEJM Catalyst Innovations in Care Delivery (17), American Journal of Managed Care (15), BMJ Open (13), Journal of Healthcare Management (11), International Journal of Healthcare Management (10) and Australian Health Review (10), with Cureus and Journal of Public Health Dentistry at 9 each. The leading Web of Science categories were Health Care Sciences and Services (271), Health Policy and Services (232), Medicine, General and Internal (104), Public, Environmental and Occupational Health (91), Surgery (46), Orthopedics (44), Nursing (32), Pharmacology and Pharmacy (26), Economics (25) and Oncology (24).

Value-based health care in Türkiye

Five included records have a Türkiye-affiliated author; only two mention Türkiye, Turkey or Turkish in the title, abstract or keywords, and they are the only Türkiye-specific evidence. A grounded theory and Delphi study with 28 health care stakeholders defined value as “a quality service”; participants supported value-based repayment despite some limitations, fifteen value measurement parameters were identified, and the authors recommend addressing resistance to change for Türkiye to adopt the model (Tekinarslan & Kaya, 2026). A retrospective comparison of Türkiye and OECD countries for 2010 to 2021, framed by VBHC, found diabetes-related DALYs consistently above the OECD average, with the gap widening from 18% in 2010 to 34% in 2021, more preventable hospital admissions in Türkiye (242.7 vs 147.9 per 100,000), rising expenditure alongside higher DALYs, and out-of-pocket spending positively correlated with the diabetes burden (Kayral & Kavak, 2026).

The other three Türkiye-affiliated records do not name Türkiye as a setting. A review suggests that HVBP and the Hospital-Acquired Conditions Program could be implemented in the public sphere “in our country”, without naming the country (Simsir & Altindis, 2019). One describes an EU-funded project that will develop a framework for using patient-generated health data to implement VBHC across the European Union (Folkvord et al., 2024), and one is a multi-country scoping review of 61 value-based payment schemes (Kumru & Or, 2027). What is missing: no study in the corpus measures outcomes with PROMs or standard sets in Türkiye, costs a care cycle with TDABC, organises care in an IPU, or evaluates a value-based payment programme there.

Debates and contradictions in the literature

Value for whom: patient, payer or society? VBHC is intended to take the patient perspective (Tsevat & Moriates, 2018), yet in cancer care cost conceptions are often payer-focused, and few measures capture patient experience and preferences (Tseng & Hicks, 2016). Others define value as the health system’s contribution to societal wellbeing (Smith et al., 2023). Because value varies from person to person, a national standard of value is hard to apply (Ray & Kusumoto, 2016).

Outcome measurement: burden versus benefit. Measuring outcomes costs time: the patient part of a psoriasis outcome set took a median of 30 minutes (Hilhorst et al., 2023), and lack of time hindered PROM use in consultations (Damman et al., 2020). The benefit is not yet well documented (Bianchim et al., 2023), and standardised outcome measures may conflict with the personalisation of patient-centred care (Kidanemariam et al., 2023).

Payment reform effects versus unintended consequences. Higher-intensity programmes are more often associated with desired results (Pandey et al., 2023), but design details can backfire, as when a spending metric rewarded low-quality hospitals (Das et al., 2016). Penalties, not bonuses, were associated with process improvement in one hospital study (Lee et al., 2020), while only 52 nursing facilities that performed poorly at baseline (0.7% of below-median performers) improved enough to avoid a penalty, despite large improvements (Burke et al., 2022). The same incentive can motivate some providers and punish others.

VBHC versus health economics. VBHC and cost-effectiveness analysis overlap but differ in perspective, application and the costs and outcomes considered (Tsevat & Moriates, 2018). Some authors propose integrating them through a “VBHC-QALY” (Walraven et al., 2021), and a review notes that the incremental cost-effectiveness ratio has not met decision makers’ needs (Seixas et al., 2019).

Equity risks. Most studies reviewed on Medicare hospital programmes show a tendency to exacerbate disparities, although a few found little or no worsening (Kim et al., 2022). Practices serving the most disadvantaged patients had more unstable angina admissions and higher 30-day mortality after myocardial infarction despite similar guideline-recommended care, differences attenuated after adjustment for area deprivation (Wadhera et al., 2020). In a cross-sectional study estimating the HVBP health equity adjustment due in fiscal year 2026 for 2,676 hospitals, safety-net hospitals were more likely to gain than other hospitals (84.0% vs 35.6%) (Liu et al., 2024).

Research gaps and agenda

  1. A shared conceptualisation. A common conceptualisation of VBHC is urgently needed (Kehyayan et al., 2025; van Staalduinen et al., 2022).
  2. Rigorous effect studies. Rigorous reports on hospital VBHC programmes are lacking, and pilot results need confirmation in larger samples (van Deen et al., 2017).
  3. Implementation science. A practical roadmap or guideline for implementing VBHC is still lacking (Vijverberg et al., 2022), and research is needed on implementation models for scaling VBHC, particularly in lower-resource settings (Douglas et al., 2025).
  4. How PROMs work. Evidence is limited on how PROMs work and how best to implement them for different contexts, conditions and populations (Bianchim et al., 2023), and on whether VBHC supports patient-centred care (Kidanemariam et al., 2023).
  5. Costs and financial sustainability. No study in a systematic review evaluated the effect of HVBP on health care costs (Hong et al., 2020), and standardised methods for measuring financial sustainability are lacking (Khalil et al., 2025).
  6. Equity. More explicit, conclusive and consistent evidence is needed on the impact of hospital VBP programmes on disparities (Kim et al., 2022).
  7. Transparency of contracts. How outcomes in value-based contracts are assessed, adjudicated and perform is largely unreported (P. M. Patel et al., 2026).
  8. The workforce. The effects of VBHC on health care professionals (van Engen et al., 2022) and the competencies hospital managers need in a value-based model (Walsh et al., 2020) require further research.

Implications for practice today

A roadmap for hospital managers.

  1. Agree on what value means locally. State whose perspective counts and which outcomes and costs are included (Landon et al., 2021).
  2. Start with one condition and a clear mandate. Secure an explicit decision from top management and give team leaders a mandate (Nilsson et al., 2018); appoint a clinical leader and involve patient representatives (Heijsters et al., 2022).
  3. Measure outcomes that matter. Adapt a standard set with case-mix factors (Seligman et al., 2019), choose outcomes with patients (Hilhorst et al., 2023) and plan how aggregated PROM results will be used (Damman et al., 2020).
  4. Cost the full cycle. Use patient-level costing such as TDABC rather than reimbursement amounts, with process mapping, expert input and observation (Leusder et al., 2022).
  5. Organise around the condition, step by step. Use project teams where full units are not feasible (Steinmann et al., 2022), and consider an integrated IT platform, which authors of a sarcoma model see as key (Fuchs et al., 2021).
  6. Benchmark and learn. Compare risk-adjusted results with peers and use outcomes to drive improvement, not only as study endpoints (Garcia-Lorenzo et al., 2024; van der Nat et al., 2020).
  7. Enter value-based contracts with care. Check risk adjustment, target prices and governance (Balu et al., 2026), and watch for reduced post-discharge care and penalties for serving disadvantaged patients (Chen et al., 2017; Eriksson et al., 2023).
  8. Evaluate honestly. Use comparison groups where possible and report null results, since stronger designs find fewer positive effects (Scott et al., 2018).
Indicator What it shows Example from the corpus
PROM completion rate Feasibility of routine outcome measurement 92% compliance with weekly digital follow-up in a lung cancer pathway (Demedts et al., 2021)
Coverage of a standard outcome set Whether outcomes are measured across tiers Only 3 of 47 studies reported outcomes at all six hierarchy levels (Zanotto et al., 2021)
Time-to-treatment interval Timeliness as a value-based quality indicator 37% of head and neck cancer patients started treatment within 30 days of first consultation (Schoonbeek et al., 2021)
Cost per care cycle (TDABC) The denominator of value at patient level 12-month care cycle costs for three prostate cancer treatments (Thaker et al., 2016)
Clinician experience score Staff side of value 18-item measure in four domains, Cronbach’s alpha .83 to .96 (Harrison et al., 2022)
Share of revenue in value-based payment Exposure to value-based contracts Health centres’ Layer 2 and 3 share of Medicaid revenue rose from 6.4% to 9.1% (Tobey et al., 2022)
Results stratified by social risk Equity of performance and penalties Safety-net hospitals more often penalised under HVBP (62.9% vs 51.0%) (Gilman et al., 2015)
Level of patient engagement Whether patients help improve care Co-design and collaborative teams were rare in 21 studies (van der Voorden et al., 2023)
Table 5. Indicators for monitoring a VBHC initiative, with examples from the corpus.

Summary

  • Value means health outcomes per unit of cost over the full care cycle, but definitions vary in components, perspective and scope.
  • VBHC combines outcome measurement, patient-level costing, care organised around conditions, benchmarking and payment that rewards value; most hospitals implement only one or two of these.
  • PROMs and standard sets are spreading, yet aggregated PROM data were scarcely used in Dutch forerunner projects and evidence on how PROMs improve care is limited.
  • Payment evidence is mixed: Medicare’s hospital programme showed mostly null effects, while some shared savings and capitation models report savings or better outcomes.
  • Payment programmes can penalise providers that serve disadvantaged patients unless risk adjustment and equity are built in.
  • Only two records concern Türkiye, and neither evaluates VBHC in practice.

Discussion questions

  1. Two hospitals report the same knee replacement outcomes, but one has lower full-cycle costs. What else would you check before calling it higher value?
  2. Should patients, payers or society decide which outcomes enter the value numerator?
  3. Why might a payment programme leave mortality unchanged? Use the HVBP evidence.
  4. How would you reward improvement without penalising hospitals that serve disadvantaged patients?
  5. Is an integrated practice unit realistic in your setting? What could be a first step?
  6. What would a first VBHC pilot in a Turkish hospital need in data, costing and contracts?

Further reading

  • Vijverberg et al. (2022): a map of 1,242 VBHC articles against the strategic agenda.
  • Landon et al. (2021): why definitions of value differ.
  • Van Staalduinen et al. (2022): how hospitals have implemented VBHC components.
  • Leusder et al. (2022): cost measurement in VBHC and the role of TDABC.
  • Bianchim et al. (2023): how PROMs are used in VBHC programmes.
  • Scott et al. (2018): a review of financial incentives across 44 schemes in 10 countries.
  • Douglas et al. (2025): a global scoping review of VBHC adoption in health systems.
  • Steinmann et al. (2020): a discourse analysis of the competing meanings of VBHC.

Glossary

Term Turkish Short definition
Value-based health care Değer temelli sağlık hizmeti Organising and paying for care to maximise patient outcomes relative to costs
Value Değer Health outcomes achieved per unit of cost over a full care cycle
Patient-reported outcome measures (PROMs) Hasta bildirimli sonuç ölçümleri Instruments capturing symptoms, function and well-being from the patient
Standard outcome set Standart sonuç seti A minimum set of outcomes and case-mix factors for a condition
Time-driven activity-based costing Zaman temelli faaliyet tabanlı maliyetleme Costing based on the time and resources each care activity uses
Integrated practice unit Entegre uygulama birimi A multidisciplinary team organised around a medical condition
Bundled payment Paket ödeme One payment for all services in an episode of care
Value-based purchasing Değer temelli satın alma Purchaser payments adjusted by performance on value metrics
Pay for performance Performansa dayalı ödeme Bonuses or penalties linked to performance measures
Case-mix adjustment Vaka karması düzeltmesi Adjusting results for patient differences so providers can be compared

Frequently asked questions

What is value in health care? Health outcomes achieved per dollar spent (Galvin et al., 2019), with the total cost of a complete care cycle as the denominator (Sheckter et al., 2019).

Is VBHC the same as value-based payment? No. Pay for performance is a contractual incentive, while VBHC is an organisational paradigm that requires care redesign and longitudinal measurement of outcomes and costs (Bernz et al., 2026).

Does Medicare’s Hospital Value-Based Purchasing programme work? Evidence is mostly null: one large study found no effect on 30-day mortality (Figueroa et al., 2016), another found a reduction only for pneumonia (A. M. Ryan et al., 2017), and a review found no impact on processes or patient outcomes (Hong et al., 2020).

Why does costing matter? About half of the VBHC studies that measured costs relied on reimbursement amounts, while methods such as TDABC give the information needed to adjust care paths (Leusder et al., 2022).

Can value-based payment harm equity? Yes: safety-net hospitals were more often penalised, although most penalties were small (Gilman et al., 2015); fuller risk adjustment removed their gap on one measure (Johnston et al., 2019).

Related on this site: Bridging the gap between value-based healthcare and health economics: a review of the ISPOR Special Task Force report · Patient-centred care: an introduction (101) · Catastrophic health expenditure: an introduction (101)

References

  • Balu, A. R., Schwartz, B., Pean, C., Bozic, K. J., & Louie, P. K. (2026). Advancing value-based care in orthopaedic surgery: Lessons from early Center for Medicare and Medicaid Innovation models and a framework for sustainable success. JBJS Reviews, 14(10), Article e2600141. https://doi.org/10.2106/JBJS.RVW.26.00141
  • Bao, Y., McGuire, T. G., Chan, Y.-F., Eggman, A. A., Ryan, A. M., Bruce, M. L., Pincus, H. A., Hafer, E., & Unützer, J. (2017). Value-based payment in implementing evidence-based care: The Mental Health Integration Program in Washington State. American Journal of Managed Care, 23(1), 48.
  • Beauvais, B., Whitaker, Z., Kim, F., & Anderson, B. (2022). Is the Hospital Value-Based Purchasing Program associated with reduced hospital readmissions? Journal of Multidisciplinary Healthcare, 15, 1089-1099. https://doi.org/10.2147/JMDH.S358733
  • Berenson, R. A., & Ginsburg, P. B. (2019). Improving the Medicare Physician Fee Schedule: Make it part of value-based payment. Health Affairs, 38(2), 246-252. https://doi.org/10.1377/hlthaff.2018.05411
  • Bernstein, D. N., Calfee, R. P., Hammert, W. C., Rozental, T. D., Witkowski, M. L., & Porter, M. E. (2022). Value-based health care in hand surgery: Where are we & where do we go from here? The Journal of Hand Surgery, 47(10), 999-1004. https://doi.org/10.1016/j.jhsa.2022.06.019
  • Bernz, I., Rabelo, A., & Malik, A. M. (2026). Performance-based payment models and value-based health care: A semi-systematic review through theoretical lenses. Frontiers in Health Services, 6, Article 1816834. https://doi.org/10.3389/frhs.2026.1816834
  • Bianchim, M. S., Crane, E., Jones, A., Neukirchinger, B., Roberts, G., Mclaughlin, L., & Noyes, J. (2023). The implementation, use and impact of patient reported outcome measures in value-based healthcare programmes: A scoping review. PLOS ONE, 18(12), Article e0290976. https://doi.org/10.1371/journal.pone.0290976
  • Burke, R. E., Xu, Y., & Rose, L. (2022). Skilled nursing facility performance and readmission rates under value-based purchasing. JAMA Network Open, 5(2), Article e220721. https://doi.org/10.1001/jamanetworkopen.2022.0721
  • Busink, E., Canaud, B., Schröder-Bäck, P., Paulus, A. T. G., Evers, S. M. A. A., Apel, C., Bowry, S. K., & Stopper, A. (2019). Chronic kidney disease: Exploring value-based healthcare as a potential viable solution. Blood Purification, 47(1-3), 156-165. https://doi.org/10.1159/000496681
  • Chatterjee, P., Joynt, K. E., Orav, E. J., & Jha, A. K. (2012). Patient experience in safety-net hospitals: Implications for improving care and value-based purchasing. Archives of Internal Medicine, 172(16), 1204-1210. https://doi.org/10.1001/archinternmed.2012.3158
  • Chee, T. T., Ryan, A. M., Wasfy, J. H., & Borden, W. B. (2016). Current state of value-based purchasing programs. Circulation, 133(22), 2197-2205. https://doi.org/10.1161/CIRCULATIONAHA.115.010268
  • Chen, L. M., Epstein, A. M., Orav, E. J., Filice, C. E., Samson, L. W., & Joynt Maddox, K. E. (2017). Association of practice-level social and medical risk with performance in the Medicare Physician Value-Based Payment Modifier Program. JAMA, 318(5), 453-461. https://doi.org/10.1001/jama.2017.9643
  • Colldén, C., & Hellström, A. (2018). Value-based healthcare translated: A complementary view of implementation. BMC Health Services Research, 18, Article 681. https://doi.org/10.1186/s12913-018-3488-9
  • Conrad, D. A. (2015). The theory of value-based payment incentives and their application to health care. Health Services Research, 50, 2057-2089. https://doi.org/10.1111/1475-6773.12408
  • Conrad, D. A., Grembowski, D., Hernandez, S. E., Lau, B., & Marcus-Smith, M. (2014). Emerging lessons from regional and state innovation in value-based payment reform: Balancing collaboration and disruptive innovation. The Milbank Quarterly, 92(3), 568-623. https://doi.org/10.1111/1468-0009.12078
  • Dainty, K. N., Golden, B. R., Hannam, R., Webster, F., Browne, G., Mittmann, N., Stern, A., & Zwarenstein, M. (2018). A realist evaluation of value-based care delivery in home care: The influence of actors, autonomy and accountability. Social Science & Medicine, 206, 100-109. https://doi.org/10.1016/j.socscimed.2018.04.006
  • Damman, O. C., Jani, A., de Jong, B. A., Becker, A., Metz, M. J., de Bruijne, M. C., Timmermans, D. R., Cornel, M. C., Ubbink, D. T., van der Steen, M., Gray, M., & van El, C. (2020). The use of PROMs and shared decision-making in medical encounters with patients: An opportunity to deliver value-based health care to patients. Journal of Evaluation in Clinical Practice, 26(2), 524-540. https://doi.org/10.1111/jep.13321
  • Das, A., Norton, E. C., Miller, D. C., Ryan, A. M., Birkmeyer, J. D., & Chen, L. M. (2016). Adding a spending metric to Medicare’s Value-Based Purchasing Program rewarded low-quality hospitals. Health Affairs, 35(5), 898-906. https://doi.org/10.1377/hlthaff.2015.1190
  • de Barros e Silva, P. G. M., Furlan, V., Lopes, R. D., Volschan, A., De Souza, P. C. P., & Polanczyk, C. A. (2025). Value-based healthcare in cardiology: How to integrate a more comprehensive view into medical decision-making? Arquivos Brasileiros de Cardiologia, 122(2), Article e20240668. https://doi.org/10.36660/abc.20240668i
  • Demedts, I., Himpe, U., Bossuyt, J., Anthoons, G., Bode, H., Bouckaert, B., Carron, K., Dobbelaere, S., Mariën, H., Van Haecke, P., & Verbeke, W. (2021). Clinical implementation of value based healthcare: Impact on outcomes for lung cancer patients. Lung Cancer, 162, 90-95. https://doi.org/10.1016/j.lungcan.2021.10.010
  • Doucette, W. R., DeVolder, R., & Heggen, T. (2021). Evaluation of financial outcomes under a value-based payment program for community pharmacies. Journal of Managed Care & Specialty Pharmacy, 27(9), 1198-1208.
  • Douglas, A. O., Senkaiahliyan, S., Bulstra, C. A., Mita, C., Reddy, C. L., & Atun, R. (2025). Global adoption of value-based health care initiatives within health systems: A scoping review. JAMA Health Forum, 6(5), Article e250746. https://doi.org/10.1001/jamahealthforum.2025.0746
  • Engels, N., Bos, W. J. W., de Bruijn, A., van Leeuwen, R., van der Meer, N. J. M., van Uden-Kraan, C. F., de Bey, P., & van der Nat, P. B. (2024). Santeon’s lessons from a decade of implementing value-based health care. NEJM Catalyst Innovations in Care Delivery, 5(1), Article CAT230232. https://doi.org/10.1056/CAT.23.0232
  • Eriksson, T., Levin, L.-Å., & Nedlund, A.-C. (2023). The introduction of a value-based reimbursement programme: Alignment and resistance among healthcare providers. International Journal of Health Planning and Management, 38(1), 129-148. https://doi.org/10.1002/hpm.3574
  • Feeley, T. W., Fly, H. S., Albright, H., Walters, R., & Burke, T. W. (2010). A method for defining value in healthcare using cancer care as a model. Journal of Healthcare Management, 55(6), 399-411. https://doi.org/10.1097/00115514-201011000-00006
  • Figueroa, J. F., Duggan, C. E., & Joynt Maddox, K. E. (2025). Value-based payment in Medicare: Progress, challenges, and future directions. Journal of Health Politics, Policy and Law, 50(6), 1059-1079. https://doi.org/10.1215/03616878-11995200
  • Figueroa, J. F., Tsugawa, Y., Zheng, J., Orav, E. J., & Jha, A. K. (2016). Association between the Value-Based Purchasing pay for performance program and patient mortality in US hospitals: Observational study. BMJ, 353, Article i2214. https://doi.org/10.1136/bmj.i2214
  • Folkvord, F., Carlson, J. I., Ottaviano, M., Carvajal, D., Gonzalez, L. H., van de Schoot, R., Turk, E., Piera-Jiménez, J., Pontes, C., Ramiro-Pareta, M., Carot-Sans, G., Podovsovnik, E., Levasic, V., Scheckenbach, K., Wagenmann, M., Szpisjak, A., Eliasen, B., Wakim, J.-M., Ernst, M., . . . Fico, G. (2024). Using patient-generated health data more efficient and effectively to facilitate the implementation of value-based healthcare in the EU: Innovation report. Computational and Structural Biotechnology Journal, 24, 672-678. https://doi.org/10.1016/j.csbj.2024.10.026
  • Fortmann, A. L., Walker, C., Barger, K., Robacker, M., Morrisey, R., Ortwine, K., Loupasi, I., Lee, I., Hogrefe, L., Strohmeyer, C., & Philis-Tsimikas, A. (2020). Care team integration in primary care improves one-year clinical and financial outcomes in diabetes: A case for value-based care. Population Health Management, 23(6), 467-475. https://doi.org/10.1089/pop.2019.0103
  • Fredriksson, J. J., Ebbevi, D., & Savage, C. (2015). Pseudo-understanding: An analysis of the dilution of value in healthcare. BMJ Quality & Safety, 24(7), 451-457. https://doi.org/10.1136/bmjqs-2014-003803
  • French, K. E., Guzman, A. B., Rubio, A. C., Frenzel, J. C., & Feeley, T. W. (2016). Value based care and bundled payments: Anesthesia care costs for outpatient oncology surgery using time-driven activity-based costing. Healthcare: The Journal of Delivery Science and Innovation, 4(3), 173-180. https://doi.org/10.1016/j.hjdsi.2015.08.007
  • Fuchs, B., Studer, G., Bode, B., Wellauer, H., Frei, A., Theus, C., Schüpfer, G., Plock, J., Windegger, H., & Breitenstein, S. (2021). Development of a value-based healthcare delivery model for sarcoma patients. Swiss Medical Weekly, 151, Article w30047. https://doi.org/10.4414/SMW.2021.w30047
  • Gabriel, L., Casey, J., Gee, M., Palmer, C., Sinha, J., Moxham, J., & Colegate-Stone, T. J. (2019). Value-based healthcare analysis of joint replacement surgery for patients with primary hip osteoarthritis. BMJ Open Quality, 8(2), Article e000549. https://doi.org/10.1136/bmjoq-2018-000549
  • Galvin, J. W., Thompson, J. C., Thompson, A. M., Parada, S. A., Eichinger, J. K., Dickens, J. F., & Gillingham, B. L. (2019). A guide to understanding reimbursement and value-based care in the Military Health System. Military Medicine, 184(3-4), e205-e210. https://doi.org/10.1093/milmed/usy206
  • Garcia-Lorenzo, B., Gorostiza, A., Alayo, I., Castelo Zas, S., Cobos Baena, P., Gallego Camina, I., Izaguirre Narbaiza, B., Mallabiabarrena, G., Ustarroz-Aguirre, I., Rigabert, A., Balzi, W., Maltoni, R., Massa, I., Álvarez López, I., Arevalo Lobera, S., Esteban, M., Fernandez Calleja, M., Gomez Mediavilla, J., Fernandez, M., . . . Fullaondo, A. (2024). European value-based healthcare benchmarking: Moving from theory to practice. European Journal of Public Health, 34(1), 44-51. https://doi.org/10.1093/eurpub/ckad181
  • Gilman, M., Hockenberry, J. M., Adams, E. K., Milstein, A. S., Wilson, I. B., & Becker, E. R. (2015). The financial effect of value-based purchasing and the Hospital Readmissions Reduction Program on safety-net hospitals in 2014: A cohort study. Annals of Internal Medicine, 163(6), 427. https://doi.org/10.7326/M14-2813
  • Grabowski, D. C., Stevenson, D. G., Caudry, D. J., O’Malley, A. J., Green, L. H., Doherty, J. A., & Frank, R. G. (2017). The impact of nursing home pay-for-performance on quality and Medicare spending: Results from the Nursing Home Value-Based Purchasing Demonstration. Health Services Research, 52(4), 1387-1408. https://doi.org/10.1111/1475-6773.12538
  • Hamid, K. S., Nwachukwu, B. U., & Ellis, S. J. (2014). Competing in value-based health care: Keys to winning the foot race. Foot & Ankle International, 35(5), 519-528. https://doi.org/10.1177/1071100714524551
  • Harrill, W. C., & Melon, D. E. (2021). A field guide to US healthcare reform: The evolution to value-based healthcare. Laryngoscope Investigative Otolaryngology, 6(3), 590-599. https://doi.org/10.1002/lio2.575
  • Harrison, R., Manias, E., Ellis, L., Mimmo, L., Walpola, R., Roxas-Harris, B., Dobbins, T., Mitchell, R., Cowie, S., Maberly, G., Chan, C., & Hay, L. (2022). Evaluating clinician experience in value-based health care: The development and validation of the Clinician Experience Measure (CEM). BMC Health Services Research, 22(1), Article 1484. https://doi.org/10.1186/s12913-022-08900-8
  • Heijsters, F. A. C. J., van Breda, F. G. F., van Nassau, F., van der Steen, M. K. J., ter Wee, P. M., Mullender, M. G., & de Bruijne, M. C. (2022). A pragmatic approach for implementation of value-based healthcare in Amsterdam UMC, the Netherlands. BMC Health Services Research, 22(1), Article 550. https://doi.org/10.1186/s12913-022-07919-1
  • Hernandez, A., Kaplan, R. S., Witkowski, M. L., Faison, C. F., III, & Porter, M. E. (2019). Navy Medicine introduces value-based health care. Health Affairs, 38(8), 1393-1400. https://doi.org/10.1377/hlthaff.2019.00280
  • Hilhorst, N. T., Deprez, E., Balak, D. M. W., Van Geel, N., Gutermuth, J., Hoorens, I., & Lambert, J. L. W. (2023). Initiating value-based healthcare in psoriasis: Proposing a value-based outcome set for daily clinical practice. Journal of the European Academy of Dermatology and Venereology, 37(3), 528-539. https://doi.org/10.1111/jdv.18696
  • Hong, Y.-R., Nguyen, O., Yadav, S., Etzold, E., Song, J., Duncan, R. P., & Turner, K. (2020). Early performance of Hospital Value-based Purchasing Program in Medicare: A systematic review. Medical Care, 58(8), 734-743. https://doi.org/10.1097/MLR.0000000000001354
  • Jayakumar, P., Puckett, H. D., Kleinsmith, R. M., & Cunningham, B. P. (2026). Patient-level value analysis: A model for implementing the concept of value-based healthcare into clinical practice. Journal of the American Academy of Orthopaedic Surgeons, 34(9), e1165-e1174. https://doi.org/10.5435/JAAOS-D-25-00568
  • Johnston, K. J., Wen, H., Schootman, M., & Joynt Maddox, K. E. (2019). Association of patient social, cognitive, and functional risk factors with preventable hospitalizations: Implications for physician value-based payment. Journal of General Internal Medicine, 34(8), 1645-1652. https://doi.org/10.1007/s11606-019-05009-3
  • Joynt Maddox, K. E., Bleser, W. K., Crook, H. L., Nelson, A. J., Lopez, M. H., Saunders, R. S., McClellan, M. B., & Brown, N. (2020). Advancing value-based models for heart failure: A call to action from the Value in Healthcare Initiative’s Value-Based Models Learning Collaborative. Circulation: Cardiovascular Quality and Outcomes, 13(5), 248-260. https://doi.org/10.1161/CIRCOUTCOMES.120.006483
  • Kamal, R. N., Lindsay, S. E., & Eppler, S. L. (2018). Patients should define value in health care: A conceptual framework. The Journal of Hand Surgery, 43(11), 1030-1034. https://doi.org/10.1016/j.jhsa.2018.03.036
  • Kayral, I. H., & Kavak, D. G. (2026). Diabetes burden and health expenditure in Türkiye and OECD countries: A value-based health care perspective. Pakistan Journal of Medical Sciences, 42(8), 1968-1972. https://doi.org/10.12669/pjms.42.8.14019
  • Kehyayan, V., Yasin, Y. M., & Al-Hamad, A. (2025). Toward a clearer understanding of value-based healthcare: A concept analysis. Journal of Nursing Management, 2025(1), Article 8186530. https://doi.org/10.1155/jonm/8186530
  • Khalil, H., Ameen, M., Davies, C., & Liu, C. (2025). Implementing value-based healthcare: A scoping review of key elements, outcomes, and challenges for sustainable healthcare systems. Frontiers in Public Health, 13, Article 1514098. https://doi.org/10.3389/fpubh.2025.1514098
  • Kidanemariam, M., Pieterse, A. H., van Staalduinen, D. J., Bos, W. J. W., & Stiggelbout, A. M. (2023). Does value-based healthcare support patient-centred care? A scoping review of the evidence. BMJ Open, 13(7), Article e070193. https://doi.org/10.1136/bmjopen-2022-070193
  • Kim, H., Mahmood, A., Hammarlund, N. E., & Chang, C. F. F. (2022). Hospital value-based payment programs and disparity in the United States: A review of current evidence and future perspectives. Frontiers in Public Health, 10, Article 882715. https://doi.org/10.3389/fpubh.2022.882715
  • Kissam, S. M., Beil, H., Cousart, C., Greenwald, L. M., & Lloyd, J. T. (2019). States encouraging value-based payment: Lessons from CMS’s State Innovation Models Initiative. The Milbank Quarterly, 97(2), 506-542. https://doi.org/10.1111/1468-0009.12380
  • Kumru, S., & Or, Z. (2027). Design and impact of value-based payment: A scoping review of schemes implemented or active between 2010 and 2024. Health Policy, 175, Article 105809. https://doi.org/10.1016/j.healthpol.2026.105809
  • Landi, S., Maistri, G., Orsini, L. P., Leardini, C., Malandra, S., & Antonelli, A. (2025). Supporting managerial decisions: A comparison of new robotic platforms through time-driven activity-based costing within a value-based healthcare framework. BMC Health Services Research, 25(1), Article 470. https://doi.org/10.1186/s12913-025-12598-9
  • Landon, S. N., Padikkala, J., & Horwitz, L. I. (2021). Defining value in health care: A scoping review of the literature. International Journal for Quality in Health Care, 33(4), Article mzab140. https://doi.org/10.1093/intqhc/mzab140
  • Leao, D. L. L., Cremers, H.-P., van Veghel, D., Pavlova, M., & Groot, W. (2023). The impact of value-based payment models for networks of care and transmural care: A systematic literature review. Applied Health Economics and Health Policy, 21(3), 441-466. https://doi.org/10.1007/s40258-023-00790-z
  • Lee, S. J., Venkataraman, S., Heim, G. R., Roth, A. V., & Chilingerian, J. (2020). Impact of the Value-Based Purchasing Program on hospital operations outcomes: An econometric analysis. Journal of Operations Management, 66(1-2), 151-175. https://doi.org/10.1002/joom.1057
  • Leusder, M., Porte, P., Ahaus, K., & van Elten, H. (2022). Cost measurement in value-based healthcare: A systematic review. BMJ Open, 12(12), Article e066568. https://doi.org/10.1136/bmjopen-2022-066568
  • Liu, M., Sandhu, S., Joynt Maddox, K. E., & Wadhera, R. K. (2024). Health equity adjustment and hospital performance in the Medicare Value-Based Purchasing Program. JAMA, 331(16), 1387-1396. https://doi.org/10.1001/jama.2024.2440
  • Lobatto, D. J., Zamanipoor Najafabadi, A. H., de Vries, F., Andela, C. D., van den Hout, W. B., Pereira, A. M., Peul, W. C., Vliet Vlieland, T. P. M., van Furth, W. R., & Biermasz, N. R. (2019). Toward value based health care in pituitary surgery: Application of a comprehensive outcome set in perioperative care. European Journal of Endocrinology, 181(4), 375-387. https://doi.org/10.1530/EJE-19-0344
  • MacLean, C. (2017). Value-based purchasing for osteoarthritis and total knee arthroplasty: What role for patient-reported outcomes? Journal of the American Academy of Orthopaedic Surgeons, 25, S55-S59. https://doi.org/10.5435/JAAOS-D-16-00638
  • Mandal, A. K., Tagomori, G. K., Felix, R. V., & Howell, S. C. (2017). Value-based contracting innovated Medicare Advantage healthcare delivery and improved survival. American Journal of Managed Care, 23(2), e41.
  • Milad, M. A., Murray, R. C., Navathe, A. S., & Ryan, A. M. (2022). Value-based payment models in the commercial insurance sector: A systematic review. Health Affairs, 41(4), 540-548. https://doi.org/10.1377/hlthaff.2021.01020
  • Mokhtary, S., Janati, A., Yousefi, M., & Raei, B. (2024). Evidence on the effectiveness of value-based payment schemes implemented in a hospital setting: A systematic review. Journal of Education and Health Promotion, 13(1), Article 327. https://doi.org/10.4103/jehp.jehp_873_23
  • Moss, H. A., & Havrilesky, L. J. (2018). The use of patient-reported outcome tools in gynecologic oncology research, clinical practice, and value-based care. Gynecologic Oncology, 148(1), 12-18. https://doi.org/10.1016/j.ygyno.2017.11.011
  • Nguyen, M. C., Moffatt-Bruce, S. D., Van Buren, A., Gonsenhauser, I., & Eiferman, D. S. (2018). Daily review of AHRQ patient safety indicators has important impact on value-based purchasing, reimbursement, and performance scores. Surgery, 163(3), 542-546. https://doi.org/10.1016/j.surg.2017.10.048
  • Nilsson, K., Bååthe, F., Andersson, A. E., & Sandoff, M. (2017). Value-based healthcare as a trigger for improvement initiatives. Leadership in Health Services, 30(4), 364-377. https://doi.org/10.1108/LHS-09-2016-0045
  • Nilsson, K., Bååthe, F., Andersson, A. E., & Sandoff, M. (2018). The need to succeed: Learning experiences resulting from the implementation of value-based healthcare. Leadership in Health Services, 31(1), 2-16. https://doi.org/10.1108/LHS-08-2016-0039
  • Novikov, D., Cizmic, Z., Feng, J. E., Iorio, R., & Meftah, M. (2018). The historical development of value-based care: How we got here. Journal of Bone and Joint Surgery: American Volume, 100(22), Article e144. https://doi.org/10.2106/JBJS.18.00571
  • Oemrawsingh, A., van Leeuwen, N., Venema, E., Limburg, M., de Leeuw, F.-E., Wijffels, M. P., de Groot, A. J., Hilkens, P. H. E., Hazelzet, J. A., Dippel, D. W. J., Bakker, C. H., Voogdt-Pruis, H. R., & Lingsma, H. F. (2019). Value-based healthcare in ischemic stroke care: Case-mix adjustment models for clinical and patient-reported outcomes. BMC Medical Research Methodology, 19(1), Article 229. https://doi.org/10.1186/s12874-019-0864-z
  • Owens, K., Eggers, J., Keller, S., & McDonald, A. (2017). The imperative of culture: A quantitative analysis of the impact of culture on workforce engagement, patient experience, physician engagement, value-based purchasing, and turnover. Journal of Healthcare Leadership, 9, 25-31. https://doi.org/10.2147/JHL.S126381
  • Pandey, A., Eastman, D., Hsu, H., Kerrissey, M. J., Rosenthal, M. B., & Chien, A. T. (2023). Value-based purchasing design and effect: A systematic review and analysis. Health Affairs, 42(6), 813-821. https://doi.org/10.1377/hlthaff.2022.01455
  • Patel, P. M., Sheehan, A. H., Wan, C., Reed, J. B., Opran, I., Small, A., & Renfro, C. P. (2026). Value-based contracting for cell and gene therapies: A scoping review of payer-manufacturer agreements and treatment center considerations in the United States. Transplantation and Cellular Therapy, 32(8), 997-1008. https://doi.org/10.1016/j.jtct.2026.03.037
  • Patel, T. A., Jain, B., & Parikh, R. B. (2023). The Enhancing Oncology Model: Leveraging improvement science to increase health equity in value-based care. JNCI: Journal of the National Cancer Institute, 115(2), 125-130. https://doi.org/10.1093/jnci/djac194
  • Peiffer, V., Yock, C. A., Yock, P. G., & Pietzsch, J. B. (2019). Value-based care: A review of key challenges and opportunities relevant to medical technology innovators. Journal of Medical Devices: Transactions of the ASME, 13(2), Article 020801. https://doi.org/10.1115/1.4042794
  • Qi, A. C., Luke, A. A., Crecelius, C., & Joynt Maddox, K. E. (2020). Performance and penalties in year 1 of the Skilled Nursing Facility Value-Based Purchasing Program. Journal of the American Geriatrics Society, 68(4), 826-834. https://doi.org/10.1111/jgs.16299
  • Ray, J. C., & Kusumoto, F. (2016). The transition to value-based care. Journal of Interventional Cardiac Electrophysiology, 47(1), 61-68. https://doi.org/10.1007/s10840-016-0166-x
  • Roberts, E. T., Zaslavsky, A. M., & McWilliams, J. M. (2018). The Value-Based Payment Modifier: Program outcomes and implications for disparities. Annals of Internal Medicine, 168(4), 255. https://doi.org/10.7326/M17-1740
  • Robinson, J. C. (2008). Value-based purchasing for medical devices. Health Affairs, 27(6), 1523-1531. https://doi.org/10.1377/hlthaff.27.6.1523
  • Ryan, A. M., Krinsky, S., Maurer, K. A., & Dimick, J. B. (2017). Changes in hospital quality associated with Hospital Value-Based Purchasing. New England Journal of Medicine, 376(24), 2358-2366. https://doi.org/10.1056/NEJMsa1613412
  • Ryan, S. P., Plate, J. F., Black, C. S., Howell, C. B., Jiranek, W. A., Bolognesi, M. P., & Seyler, T. M. (2019). Value-based care has not resulted in biased patient selection: Analysis of a single center’s experience in the Care for Joint Replacement Bundle. The Journal of Arthroplasty, 34(9), 1872-1875. https://doi.org/10.1016/j.arth.2019.04.052
  • Saleh, K. J., & Shaffer, W. O. (2016). Understanding value-based reimbursement models and trends in orthopaedic health policy: An introduction to the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015. Journal of the American Academy of Orthopaedic Surgeons, 24(11), e136-e147. https://doi.org/10.5435/JAAOS-D-16-00283
  • Schoonbeek, R. C., de Vries, J., Bras, L., Plaat, B. E. C., van Dijk, B. A. C., & Halmos, G. B. (2021). Determinants of delay in the head and neck oncology care pathway: The next step in value-based health care. European Journal of Cancer Care, 30(4), Article e13419. https://doi.org/10.1111/ecc.13419
  • Scott, A., Liu, M., & Yong, J. (2018). Financial incentives to encourage value-based health care. Medical Care Research and Review, 75(1), 3-32. https://doi.org/10.1177/1077558716676594
  • Seechoonparsad, P., Rogers, C., Soong, J., Botzenhardt, F., Giusti, G., Martinache, J., Hunt, K., Floriano, L., Santoso, C., Morgado, S., Cabrera, L., Shen, C., Blaszczak, A., Inczédy, C., Popp, C., & Velickovic, V. M. (2026). Value-based procurement and tenders for medical devices with application to wound care: International perspectives and practical opportunities. Current Medical Research and Opinion, 42(3), 541-558. https://doi.org/10.1080/03007995.2026.2674800
  • Seixas, B. V., Dionne, F., Conte, T., & Mitton, C. (2019). Assessing value in health care: Using an interpretive classification system to understand existing practices based on a systematic review. BMC Health Services Research, 19(1), Article 560. https://doi.org/10.1186/s12913-019-4405-6
  • Seligman, W. H., Salt, M., De la Torre Rosas, A., & Das-Gupta, Z. (2019). Unlocking the potential of value-based health care by defining global standard sets of outcome measures that matter to patients with cardiovascular diseases. European Heart Journal: Quality of Care and Clinical Outcomes, 5(2), 92-95. https://doi.org/10.1093/ehjqcco/qcy056
  • Sheckter, C. C., Matros, E., Lee, G. K., Selber, J. C., & Offodile, A. C., II (2019). Applying a value-based care framework to post-mastectomy reconstruction. Breast Cancer Research and Treatment, 175(3), 547-551. https://doi.org/10.1007/s10549-019-05212-0
  • Simsir, I., & Altindis, S. (2019). Could value-based purchasing approach be used in assessment of healthcare delivery outputs? Konuralp Tıp Dergisi, 11(3), 475-481. https://doi.org/10.18521/ktd.591897
  • Smith, P. C., Sagan, A., Siciliani, L., & Figueras, J. (2023). Building on value-based health care: Towards a health system perspective. Health Policy, 138, Article 104918. https://doi.org/10.1016/j.healthpol.2023.104918
  • Spaulding, A., Zhao, M., & Haley, D. R. (2014). Value-based purchasing and hospital acquired conditions: Are we seeing improvement? Health Policy, 118(3), 413-421. https://doi.org/10.1016/j.healthpol.2014.10.003
  • Steinmann, G., Daniels, K., Mieris, F., Delnoij, D., van de Bovenkamp, H., & van Der Nat, P. (2022). Redesigning value-based hospital structures: A qualitative study on value-based health care in the Netherlands. BMC Health Services Research, 22(1), Article 1193. https://doi.org/10.1186/s12913-022-08564-4
  • Steinmann, G., Delnoij, D., van de Bovenkamp, H., Groote, R., & Ahaus, K. (2021). Expert consensus on moving towards a value-based healthcare system in the Netherlands: A Delphi study. BMJ Open, 11(4), Article e043367. https://doi.org/10.1136/bmjopen-2020-043367
  • Steinmann, G., van de Bovenkamp, H., de Bont, A., & Delnoij, D. (2020). Redefining value: A discourse analysis on value-based health care. BMC Health Services Research, 20(1), Article 862. https://doi.org/10.1186/s12913-020-05614-7
  • Strazzabosco, M., Allen, J. I., & Teisberg, E. O. (2017). Value-based care in hepatology. Hepatology, 65(5), 1749-1755. https://doi.org/10.1002/hep.29042
  • Tekinarslan, M., & Kaya, S. (2026). A qualitative research on the applicability of value-based payment method in the health system of Türkiye. Sosyoekonomi, 34(69), 453-471. https://doi.org/10.17233/sosyoekonomi.2026.03.21
  • Teshale, S. M., Schwartz, M. L., Thomas, K. S., & Mroz, T. M. (2021). Early effects of Home Health Value-Based Purchasing on quality star ratings. Medical Care Research and Review, 78(6), 747-757. https://doi.org/10.1177/1077558720952298
  • Thaker, N. G., Ali, T. N., Porter, M. E., Feeley, T. W., Kaplan, R. S., & Frank, S. J. (2016). Communicating value in health care using radar charts: A case study of prostate cancer. Journal of Oncology Practice, 12(9), 813. https://doi.org/10.1200/JOP.2016.011320
  • Tobey, R., Maxwell, J., Turer, E., Singer, E., Lindenfeld, Z., Nocon, R. S., Coleman, A., Bolton, J., Hoang, H., Sripipatana, A., & Huang, E. S. (2022). Health centers and value-based payment: A framework for health center payment reform and early experiences in Medicaid value-based payment in seven states. The Milbank Quarterly, 100(3), 879-917.
  • Tseng, E. K., & Hicks, L. K. (2016). Value based care and patient-centered care: Divergent or complementary? Current Hematologic Malignancy Reports, 11(4), 303-310. https://doi.org/10.1007/s11899-016-0333-2
  • Tsevat, J., & Moriates, C. (2018). Value-based health care meets cost-effectiveness analysis. Annals of Internal Medicine, 169(5), 329. https://doi.org/10.7326/M18-0342
  • van Deen, W. K., Esrailian, E., & Hommes, D. W. (2015). Value-based health care for inflammatory bowel diseases. Journal of Crohn’s and Colitis, 9(5), 421-427. https://doi.org/10.1093/ecco-jcc/jjv036
  • van Deen, W. K., Spiro, A., Ozbay, A. B., Skup, M., Centeno, A., Duran, N. E., Lacey, P. N., Jatulis, D., Esrailian, E., van Oijen, M. G. H., & Hommes, D. W. (2017). The impact of value-based healthcare for inflammatory bowel diseases on healthcare utilization: A pilot study. European Journal of Gastroenterology & Hepatology, 29(3), 331-337. https://doi.org/10.1097/MEG.0000000000000782
  • van der Nat, P. B., van Veghel, D., Daeter, E., Crijns, H. J., Koolen, J., Houterman, S., Soliman, M. A., & de Mol, B. A. (2020). Insights on value-based healthcare implementation from Dutch heart care. International Journal of Healthcare Management, 13(3), 189-192. https://doi.org/10.1080/20479700.2017.1397307
  • van der Voorden, M., Sipma, W. S., de Jong, M. F. C., Franx, A., & Ahaus, K. C. T. B. (2023). The immaturity of patient engagement in value-based healthcare: A systematic review. Frontiers in Public Health, 11, Article 1144027. https://doi.org/10.3389/fpubh.2023.1144027
  • van Engen, V., Bonfrer, I., Ahaus, K., & Buljac-Samardzic, M. (2022). Value-based healthcare from the perspective of the healthcare professional: A systematic literature review. Frontiers in Public Health, 9, Article 800702. https://doi.org/10.3389/fpubh.2021.800702
  • van Staalduinen, D. J., van den Bekerom, P., Groeneveld, S., Kidanemariam, M., Stiggelbout, A. M., & Van den Akker-van Marle, M. E. (2022). The implementation of value-based healthcare: A scoping review. BMC Health Services Research, 22(1), Article 270. https://doi.org/10.1186/s12913-022-07489-2
  • Vijverberg, J. R. G., Daniels, K., Steinmann, G., Garvelink, M. M., van der Voort, M. B. V. R., Biesma, D., Bos, W. J. W., van Merode, F., & van der Nat, P. (2022). Mapping the extent, range and nature of research activity on value-based healthcare in the 15 years following its introduction (2006-2021): A scoping review. BMJ Open, 12(8), Article e064983. https://doi.org/10.1136/bmjopen-2022-064983
  • Wadhera, R. K., Bhatt, D. L., Kind, A. J. H., Song, Y., Williams, K. A., Maddox, T. M., Yeh, R. W., Dong, L., Doros, G., Turchin, A., & Joynt Maddox, K. E. (2020). Association of outpatient practice-level socioeconomic disadvantage with quality of care and outcomes among older adults with coronary artery disease: Implications for value-based payment. Circulation: Cardiovascular Quality and Outcomes, 13(4), Article e005977. https://doi.org/10.1161/CIRCOUTCOMES.119.005977
  • Walraven, J., Jacobs, M. S., & Uyl-de Groot, C. A. (2021). Leveraging the similarities between cost-effectiveness analysis and value-based healthcare. Value in Health, 24(7), 1038-1044. https://doi.org/10.1016/j.jval.2021.01.010
  • Walsh, A. P., Harrington, D., & Hines, P. (2020). Are hospital managers ready for value-based healthcare? A review of the management competence literature. International Journal of Organizational Analysis, 28(1), 49-65. https://doi.org/10.1108/IJOA-01-2019-1639
  • Wang, J., Zhong, L., Xiong, S., Min, S., & Gong, N. (2026). Expert narrative review on the impact of value-based healthcare on medical quality and patient safety system restructuring. BMC Health Services Research, 26(1), Article 697. https://doi.org/10.1186/s12913-026-14423-3
  • Wiersema, J. E., Bresser, C. C., & van der Nat, P. B. (2023). Organizing care around conditions: An expanded model of value-based health care. NEJM Catalyst Innovations in Care Delivery, 4(12), Article CAT230180. https://doi.org/10.1056/CAT.23.0180
  • Wise, S., Hall, J., Haywood, P., Khana, N., Hossain, L., & van Gool, K. (2022). Paying for value: Options for value-based payment reform in Australia. Australian Health Review, 46(2), 129-133. https://doi.org/10.1071/AH21115
  • Withers, K., Palmer, R., Lewis, S., & Carolan-Rees, G. (2021). First steps in PROMs and PREMs collection in Wales as part of the prudent and value-based healthcare agenda. Quality of Life Research, 30(11), 3157-3170. https://doi.org/10.1007/s11136-020-02711-2
  • Zanotto, B. S., Beck da Silva Etges, A. P., Marcolino, M. A. Z., & Polanczyk, C. A. (2021). Value-based healthcare initiatives in practice: A systematic review. Journal of Healthcare Management, 66(5), 340-365. https://doi.org/10.1097/JHM-D-20-00283

Source verification and use of AI. Author names, publication years, titles, journals, volumes, pages and DOIs in the reference list were taken from the Web of Science records of the included studies, with author names taken from the full-name (AF) field; journal names were normalised from the capitalised Web of Science form, and titles were set in sentence case. Initials follow the full given names in AF, keeping hyphens and suffixes; author names were corrected only for obvious export errors (split compound surnames, one author recorded under different surname forms) and diacritics. Two missing article numbers were completed from the DOI, and the missing pages of one record from the citation line in its Web of Science abstract field. Claims attributed to sources were checked against the abstracts in an independent verification at abstract level; full texts were not reviewed, so numbers are reported as the abstracts state them. AI tools were used to support title and abstract screening, to extract evidence from abstracts into a structured template, to draft the text and to generate the figures. Responsibility for the content rests with the author, Prof. Dr. Mehmet Nurullah Kurutkan.

Data and supplementary material. The full list of the 802 included records, the screening log and the verification report are provided in the supplementary file “VB_101_supplementary.xlsx”, available from the author on request.

Cite this page (APA 7)

Kurutkan, M. N. (2026, November 19). Value-Based Health Care: An Introduction (101). The Health Topics. https://healthtopic.org/topics/value-based-health-care-an-introduction-101/

Subscribe to the Health Topics Newsletter!

Google reCaptcha: Invalid site key.